A healthy upside potential exists for Protalix BioTherapeutics Inc. (PLX) Stock

H.C. Wainwright raised the price target for the Protalix BioTherapeutics Inc. (AMEX:PLX) stock to “a Buy”. The rating was released on June 08, 2020, according to finviz. We previously noted in another research note published on April 17, 2017 by Rodman & Renshaw that reiterated the stock to a Buy with a price target of […]